Showing results (161-170 of 912) with videos related to
Sort By:
Pageof 92
Annals of General Psychiatry|February 18, 2015
Prognostic influence of witness/victim experiences and PTSD-specific symptoms on working and educational capacity: a comparison between two groups of individuals post-traumaHelge H Müller, Sebastian Moeller, York Hilger, et al.Annals of General Psychiatry|February 12, 2015
New DSM-5 maladaptive symptoms in PTSD: gender differences and correlations with mood spectrum symptoms in a sample of high school students following survival of an earthquakeClaudia Carmassi, Paolo Stratta, Gabriele Massimetti, et al.Annals of General Psychiatry|March 27, 2015
Saliva secretion disorder in a schizophrenic patient - a problem in dental and psychiatric treatment: a case reportDanuta Maria MośAnnals of General Psychiatry|May 22, 2020
MDMA-assisted psychotherapy for people diagnosed with treatment-resistant PTSD: what it is and what it isn'tLouise MorganAnnals of General Psychiatry|March 11, 2023
Cognitive function in recovered COVID-19 Lebanese patients with schizophreniaChadia Haddad, Angela Chamoun, Hala Sacre, et al.Annals of General Psychiatry|March 14, 2023
Participation in leisure activities and quality of life of people with psychosis in England: a multi-site cross-sectional studyKayonda Hubert Ngamaba, Martin Webber, Penny Xanthopoulou, et al.Annals of General Psychiatry|November 19, 2025
The association between sleep onset time and depression among U.S. adults: a cross-sectional study from NHANES 2015-2020Kunming Bao, Dongjun Bao, Xiaoming Li, et al.Annals of General Psychiatry|November 19, 2025
Vortioxetine effectiveness in the treated major depressive disorder patients in Saudi ArabiaAli Garatli, Sherif Saad, Rafat Alowesei, et al.Annals of General Psychiatry|January 21, 2026
Beyond inflammation and cholesterol: atherogenic index of plasma mediates the link between hsCRP/HDL-C ratio and depression in US adults NHANES 2015-2020Jing-Ying Ma, Jue Hu, FaDan Tang, et al.Annals of General Psychiatry|December 30, 2025
Managing schizophrenia with affective, sexual, metabolic and substance-use comorbidities: pharmacological considerations from an expert consensusEduard Vieta, Ángel L Montejo, Toby Pillinger, et al.Pageof 92